An episomal CRISPR/Cas9 system to derive vector-free gene modified mammalian cells

Linlin Li; Fei Gao; Sen Wu

doi:10.1007/s13238-016-0299-9

PDF(582 KB)

Protein Cell ›› 2016, Vol. 7 ›› Issue (9) : 689-691. DOI: 10.1007/s13238-016-0299-9

LETTER

An episomal CRISPR/Cas9 system to derive vector-free gene modified mammalian cells

Author information +

History +

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Linlin Li, Fei Gao, Sen Wu. An episomal CRISPR/Cas9 system to derive vector-free gene modified mammalian cells. Protein Cell, 2016, 7(9): 689‒691 https://doi.org/10.1007/s13238-016-0299-9

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA (2013) Multiplex genome engineering using CRISPR/Cas systems. Science 339:819–823 CrossRef Google scholar

[2]	Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW, Sands MS (2007) AAV vector integration sites in mouse hepatocellular carcinoma. Science 317:477 CrossRef Google scholar

[3]	Kouranova E, Forbes K, Zhao G, Warren J, Bartels A, Wu Y, Cui X (2016) CRISPRs for optimal targeting: delivery of CRISPR components as DNA, RNA and protein into cultured cells and single-cell embryos. Hum Gene Ther 27:464–475 CrossRef Google scholar

[4]	Li H, Malani N, Hamilton SR, Schlachterman A, Bussadori G, Edmonson SE, Shah R, Arruda VR, Mingozzi F, Wright JF (2011) Assessing the potential for AAV vector genotoxicity in a murine model. Blood 117:3311–3319 CrossRef Google scholar

[5]	Lin S, Staahl BT, Alla RK, Doudna JA (2014) Enhanced homologydirected human genome engineering by controlled timing of CRISPR/Cas9 delivery. eLife 3:e04766 CrossRef Google scholar

[6]	Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339:823–826 CrossRef Google scholar

[7]	Nanbo A, Sugden A, Sugden B (2007) The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J 26:4252–4262 CrossRef Google scholar

[8]	Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8:U409–U452 CrossRef Google scholar

[9]	Yin H, Song CQ, Dorkin JR, Zhu LJ, Li Y, Wu Q, Park A, Yang J, Suresh S, Bizhanova A (2016) Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo. Nat Biotechnol 34:328–333 CrossRef Google scholar

[10]	Yu JY, Hu KJ, Smuga-Otto K, Tian SL, Stewart R, Slukvin II, Thomson JA (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324:797–801 CrossRef Google scholar